Lidocaine
- Generic Name
- Lidocaine
- Brand Names
- Agoneaze, Akten, Alivio, Anestacon, Anodyne Lpt, Astero, Band-aid Hurt-free, Cathejell, Curacaine, Depo-medrol With Lidocaine, Dermacinrx Lido V Pak, Dermacinrx Phn Pak, Dermacinrx Prikaan, Diphen, Emla, Fortacin, Glydo, Instillagel, Kenalog, Lido Bdk, Lido-prilo Caine Pack, Lidocan, Lidodan, Lidoderm, Lidopac, Lidopril, Lidopro, Lidosol, Lidothol, Lidotral, Lignospan, Marcaine, Max-freeze, Medi-derm With Lidocaine, Neo-bex, Octocaine, Octocaine With Epinephrine, Oraqix, P-care, P-care X, Pliaglis, Prilolid, Prizotral, Procomycin, Readysharp Anesthetics Plus Ketorolac, Readysharp-A, Readysharp-p40, Readysharp-p80, Relador, Synera, Triple Antibiotic, Venipuncture Px1, Viadur, Xylocaine, Xylocaine With Epinephrine, Xylocard, Xylonor, Zingo, Ztlido
- Drug Type
- Small Molecule
- Chemical Formula
- C14H22N2O
- CAS Number
- 137-58-6
- Unique Ingredient Identifier
- 98PI200987
- Background
Ever since its discovery and availability for sale and use in the late 1940s, lidocaine has become an exceptionally commonly used medication . In particular, lidocaine's principal mode of action in acting as a local anesthetic that numbs the sensations of tissues means the agent is indicated for facilitating local anesthesia for a large variety of surgical p...
- Indication
Lidocaine is an anesthetic of the amide group indicated for production of local or regional anesthesia by infiltration techniques such as percutaneous injection and intravenous regional anesthesia by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks .
- Associated Conditions
- Acute Otitis Media (AOM), Anorectal discomfort, Arrhythmia, Back Pain Lower Back, Bacterial Vaginosis (BV), Burns, Cervical Syndrome, Earache, Fissure;Anal, Haemorrhoids, Infection, Inflammatory Reaction caused by ear infection-not otherwise specified, Insect Bites, Joint Pain, Mixed Vaginal Infections, Multiple Myeloma (MM), Myringitis, Neuritis, Osteolysis caused by Bone Tumors, Osteoporosis, Otitis Externa, Pain caused by ear infection-not otherwise specified, Pain, Inflammatory, Postherpetic Neuralgia, Primary Hyperparathyroidism (PHPT), Rheumatic Diseases, Rheumatic Joint Disease, Sciatica, Skin Irritation, Soft Tissue Inflammation, Sore Throat, Sunburn, Susceptible infections, Trichomonas Vaginitis, Ulcers, Leg, Urethral Strictures, Ventricular Arrhythmia, Vulvovaginal Candidiasis, Abrasions, Anal discomfort, Cutaneous lesions, Gum pain, Minor burns, Superficial Wounds, Susceptible Bacterial Infections, Ulceration of the mouth, Viral infections of the external ear canal
- Associated Therapies
- Local Anaesthesia therapy, Post Myocardial Infarction Treatment, Regional Anesthesia therapy
Topical Lidocaine on the Cervix and Intra-Cervical Prior to Insertion of Intrauterine Devices
- First Posted Date
- 2010-09-01
- Last Posted Date
- 2011-06-16
- Lead Sponsor
- University of Tennessee
- Target Recruit Count
- 210
- Registration Number
- NCT01192490
- Locations
- 🇺🇸
University of Tennessee Chattanooga Department of Obstetrics and Gynecology, Chattanooga, Tennessee, United States
How Lidocaine Affects Outcomes In Orthopedic Surgery Patients
- Conditions
- Interventions
- First Posted Date
- 2010-08-11
- Last Posted Date
- 2015-09-07
- Lead Sponsor
- Cedars-Sinai Medical Center
- Registration Number
- NCT01179100
- Locations
- 🇺🇸
Cedars Sinai Medical Center, Los Angeles, California, United States
Bowel Function After Laparoscopic Colon Surgery: Effect of IV Lidocaine
- Conditions
- Interventions
- First Posted Date
- 2010-07-01
- Last Posted Date
- 2011-11-28
- Lead Sponsor
- McGill University Health Centre/Research Institute of the McGill University Health Centre
- Target Recruit Count
- 60
- Registration Number
- NCT01155440
- Locations
- 🇨🇦
MUHC, Montreal, Quebec, Canada
Lidocaine and Closed-Loop Anesthesia System
- First Posted Date
- 2010-07-01
- Last Posted Date
- 2016-11-03
- Lead Sponsor
- Hopital Foch
- Target Recruit Count
- 82
- Registration Number
- NCT01154738
- Locations
- 🇫🇷
Hopital Tenon, Paris, France
Lidocaine Analgesia For Removal Of Wound Vac Dressings
- First Posted Date
- 2010-05-19
- Last Posted Date
- 2014-05-29
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 11
- Registration Number
- NCT01126359
- Locations
- 🇺🇸
University of Utah, Salt Lake City, Utah, United States
Effect of Lidocaine and Esmolol to Improve the Quality of Recovery
- Conditions
- Interventions
- First Posted Date
- 2010-05-03
- Last Posted Date
- 2016-11-03
- Lead Sponsor
- Cedars-Sinai Medical Center
- Target Recruit Count
- 32
- Registration Number
- NCT01114997
- Locations
- 🇺🇸
Cedars Sinai Medical Center, Los Angeles, California, United States
Treatment of Postoperative Pain After Total Hip Arthroplasty Using Intravenous Lidocaine Infusion
- Conditions
- Interventions
- First Posted Date
- 2010-04-22
- Last Posted Date
- 2015-04-06
- Lead Sponsor
- Loma Linda University
- Registration Number
- NCT01108562
Safety and Efficacy Study of KAI-1678 to Treat Pain in Subjects With Postherpetic Neuralgia
- Conditions
- Interventions
- First Posted Date
- 2010-04-20
- Last Posted Date
- 2011-09-01
- Lead Sponsor
- KAI Pharmaceuticals
- Target Recruit Count
- 23
- Registration Number
- NCT01106716
Using Lignocaine Spray and Gel to Reduce the Pain Associated With Nasogastric Tube Insertion in Children
- First Posted Date
- 2010-02-25
- Last Posted Date
- 2016-03-31
- Lead Sponsor
- The University of Queensland
- Target Recruit Count
- 13
- Registration Number
- NCT01075789
- Locations
- 🇦🇺
Queensland Children's Medical Research Institute, Brisbane, Queensland, Australia
Treatment of Chronic Thoracic and Neck and Upper Extremity Pain
- Conditions
- Interventions
- First Posted Date
- 2010-02-19
- Last Posted Date
- 2017-04-27
- Lead Sponsor
- Pain Management Center of Paducah
- Target Recruit Count
- 120
- Registration Number
- NCT01071369
- Locations
- 🇺🇸
Ambulatory Surgery Center, Paducah, Kentucky, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.